New #IDSAGuidelines!
IDSA has released updated evidence-based recommendations on the prevention of invasive aspergillosis in adult solid organ transplant recipients: https://t.co/yYl8psAqN0
A seven-day course of antibiotics for hospitalized patients with bloodstream infections is just as effective as a 14-day course, according to new findings presented at #IDWeek2024.
Learn more: https://t.co/WLih5XRHo7
IDSA and @HIVMA mourn the recent loss of IDSA Past President Barbara E. Murray, MD, FIDSA.
A leading authority on the role of enterococci and S. aureus in infectious diseases from the bench to the bedside, Dr. Murray was president of the Society from 2013 to 2014 and served on the IDSA Board of Directors in multiple roles, including as treasurer and as secretary.
We extend our deepest condolences to her family, friends and colleagues. #WeAreID
Happy to share this labor of love. A near decade worth of data on toxoplasma reactivation after AlloHCT. @AlexandreMALEK and I are always grateful to the mentorship of Dr. @sairah__ahmed Dr. Mulanovich Dr @RichardChamplin Dr @EJShpallMD#bmtsm#IDTwitter https://t.co/iqvUtZzUjC
Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study
✅ Just Accepted
https://t.co/g4bcV8EVDM
Study on outpatient antibiotic prescribing during #COVID19. Results: ⬇️ antibiotic initiation, broad-spectrum use, extended therapy. Inter-physician variability highlights #stewardship opportunities, from @PrnvTndn, @BRxAD et al https://t.co/zh38kzXyZM